These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20122859)

  • 1. Neuropeptide Y and sleep.
    Dyzma M; Boudjeltia KZ; Faraut B; Kerkhofs M
    Sleep Med Rev; 2010 Jun; 14(3):161-5. PubMed ID: 20122859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between NPY and CRF in the amygdala to regulate emotionality.
    Sajdyk TJ; Shekhar A; Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):225-34. PubMed ID: 15337374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis.
    Crespi EJ; Vaudry H; Denver RJ
    J Neuroendocrinol; 2004 Mar; 16(3):279-88. PubMed ID: 15049859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y.
    Inui A; Okita M; Nakajima M; Momose K; Ueno N; Teranishi A; Miura M; Hirosue Y; Sano K; Sato M; Watanabe M; Sakai T; Watanabe T; Ishida K; Silver J; Baba S; Kasuga M
    Proc Assoc Am Physicians; 1998; 110(3):171-82. PubMed ID: 9625524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S; Boey D; Herzog H
    Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropeptide Y: psychopharmacological and clinical aspects].
    Nakagawara M; Sato Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):117-27. PubMed ID: 7941776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.
    Soscia SJ; Harrington ME
    Neurosci Lett; 2005 Jan; 373(3):175-8. PubMed ID: 15619538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-sleep effects of hypocretin/orexin.
    Samson WK; Taylor MM; Ferguson AV
    Sleep Med Rev; 2005 Aug; 9(4):243-52. PubMed ID: 16036174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation.
    Ramos EJ; Meguid MM; Campos AC; Coelho JC
    Nutrition; 2005 Feb; 21(2):269-79. PubMed ID: 15723758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y: a central regulator of energy homeostasis.
    White JD
    Regul Pept; 1993 Dec; 49(2):93-107. PubMed ID: 8134618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
    Sajdyk TJ; Fitz SD; Shekhar A
    Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.
    Levens NR; Della-Zuana O
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1198-204. PubMed ID: 14649211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide-Y family of peptides in the autocrine-paracrine regulation of adrenocortical function.
    Nussdorfer GG; Gottardo G
    Horm Metab Res; 1998; 30(6-7):368-73. PubMed ID: 9694565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staying awake for dinner: hypothalamic integration of sleep, feeding, and circadian rhythms.
    Saper CB
    Prog Brain Res; 2006; 153():243-52. PubMed ID: 16876579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
    Zukowska Z; Pons J; Lee EW; Li L
    Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
    Dumont Y; Chabot JG; Quirion R
    Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.